Clinical Trial Resource Center


Therapeutic Areas: Oncology | Dermatology | Family Medicine

Squamous Cell Carcinoma Clinical Trials


A listing of Squamous Cell Carcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Tuscaloosa : DCH Cancer Center

A clinical study for patients with Basal Cell Carcinoma or Squamous Cell Carcinoma

Arizona

Casa Grande : Cancer Treatment Services - AZ

A clinical study for patients with Basal Cell Carcinoma or Squamous Cell Carcinoma

Scottsdale : Southwest Oncology Centers

A clinical study for patients with Basal Cell Carcinoma or Squamous Cell Carcinoma

Scottsdale : Mayo Clinic Arizona (Site 229) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Arkansas

Hot Springs : Genesis Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

California

Duarte : City of Hope, Site #009 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

La Jolla : Moores Cancer Center University of California, San Diego, Site #099 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

La Jolla : Moores UC San Diego Cancer Center

A clinical trial to evaluate treatments using GL-ONC1 for patients with Cancer of Head and Neck

Los Angeles : UCLA Hematology-Oncology Clinic

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles : Cedars-Sinai Medical Center

A Phase 1 clinical study for patients with EGFR Positive Solid Tumors

Oxnard : Ventura County Hematology-Oncology Specialists

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Pleasant Hill : Diablo Valley Oncology and Hematology Medical Group

A clinical study for patients with Basal Cell Carcinoma or Squamous Cell Carcinoma

San Diego : Kaiser Permanente, Site #208 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Colorado

Aurora : University of Colorado Cancer Center, Site #015 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Denver : Rocky Mountain Cancer Centers

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Connecticut

New Haven : Yale Cancer Center (Site 033) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

District of Columbia

Washington : Georgetown Lombardi Comprehensive Cancer Center

A clinical research study of Nilotinib + Cetuximab for the treatment of Colorectal Cancer or Head and Neck Cancer

Florida

Lake Worth : Cancer Center of South Florida, Site #204 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Ocala : Ocala Oncology Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Tampa : H. Lee Moffitt Cancer Center (Site 017) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Tampa : Moffitt Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Georgia

Atlanta : Winship Cancer Institute of Emory University, Site #058 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Illinois

Chicago : The University of Chicago Medical Center

A clinical research study of Everolimus escalating dose and Everolimus or Placebo for the treatment of Head and Neck Cancer

Chicago : University of Chicago (Site 001) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Chicago : The University of Chicago

A clinical trial to evaluate treatments using MGA271 for patients

Kansas

Wichita : Cancer Center of Kansas

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Kentucky

Paducah : Western Kentucky Hematology and Oncology Group

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Louisiana

Marrero : West Jefferson Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Maryland

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 1 clinical study for patients with EGFR Positive Solid Tumors

Massachusetts

Boston : Dana Farber Cancer Institute

A clinical trial to evaluate treatments using MGA271 for patients

Boston : Massachusetts General Hospital Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Boston : Dana Farber Cancer Institute

A Phase 1 clinical study for patients with EGFR Positive Solid Tumors

Michigan

Detroit : Karmanos Cancer Institute

A Phase 1 clinical study for patients with EGFR Positive Solid Tumors

Minnesota

Rochester : Mayo Clinic (Site 044) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

New Jersey

Cherry Hill : Regional Cancer Care Associates/Cherry Hill Division, LLC.

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

East Brunswick : Regional Cancer Care Associates

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Morristown : Regional Cancer Care Associates/ Carol G. Simon Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Somerville : Regional Cancer Care Associates/ Somerset Division

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

New York

Lake Success : Clinical Research Alliance

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

New York : Icahn School of Medicine at Mount Sinai

A clinical research study of ADXS11-001 (ADXS-HPV) for the treatment of Head and Neck Cancer, Squamous Cell Carcinoma of the Head and Neck or Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma

New York : Mount Sinai School of Medicine

A clinical trial to evaluate treatments for patients with Squamous Cell Carcinoma of the Head and Neck

North Carolina

Chapel Hill : Lineberger Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Chapel Hill : UNC Health Care; N.C. Cancer Hospital Infusion/Inpatient Pharmacy (CHIP) (Site 032) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Chapel Hill : The University of North Carolina at Chapel Hill

A Phase 2 clinical study for patients with Head and Neck Cancer or Squamous Cell Carcinoma of the Head and Neck

Charlotte : Novant Health Presbyterian Medical Center Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Charlotte : Novant Health Presbyterian Medical Center, Site #205 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Winston-Salem : Novant Health Oncology Specialists/Forsyth Memorial Hospital

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Oklahoma

Lawton : Cancer Centers of Southwest Oklahoma

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Pennsylvania

Philadelphia : University of Pennsylvania

A clinical trial seeking patients for a research study for the treatment of Aerodigestive Malignancies (e.g Squamous Cell Carcinoma)

Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Tennessee

Nashville : Sarah Cannon Research Institute

A clinical trial to evaluate treatments using MGA271 for patients

Texas

Amarillo : Texas Oncology, P.A.

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Dallas : Baylor University Medical Center at Dallas

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Galveston : University of Texas Medical Branch

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Houston : UT MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Paranasal Sinus Neoplasms or Squamous Cell Carcinoma

Houston : UT MD Anderson Cancer Center (Site 005) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Longview : Texas Oncology, P.A./Longview Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Washington

Seattle : Swedish Cancer Institute (Site 211) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Vancouver : Northwest Cancer Specialists, PC

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Australia

Woolloongabba : Veracity Clinical Research Pty Ltd

Patients are needed to participate in a clinical research study of BLZ-100 to evaluate Skin Neoplasms

Belgium

Roeselare : H.-Hartziekenhuis Roeselare-Menen vzw (Site 617) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Canada

Ottawa : The Ottawa Hospital Cancer Centre (Site 131) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

China

Shanghai : Shanghai Chest hospital

A clinical trial seeking patients for a research study for the treatment of Squamous Cell Carcinoma

Denmark

DK 2730 Herlev : Herlev Hospital (Site 614) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Odense C : Odense University Hospital (Site 615) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

France

Nancy : Centre Alexis Vautrin (CAV)-Nancy Université

A clinical trial to evaluate treatments using Amphinex induced PCI of bleomycin for patients with Recurrent Cancer

Germany

Berlin : Evangelische Lungenklinik Berlin (Site 588) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Halle : Krankenhaus Martha Marie Halle (Site 572) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Heidelberg : Thoraxklinik-Heidelberg gGmbH, Innere Medizin - Onkologie (Site 586) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Munchen : LMU - Klinikum der Universitat Munchen, Campus Innenstadt, Medizinische Klinik V, Pneumologie (Site 609) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

M√ľnchen : Ludwig Maximilian University Munich

A clinical trial to evaluate treatments using Amphinex induced PCI of bleomycin for patients with Recurrent Cancer

Hong Kong

Hong Kong : Queen Mary Hospital, Division of Respiratory and Critical Care Medicine (Site 973) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Hong Kong : Queen Mary Hospital, Department of Clinical Oncology (Site 986) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Italy

Parma : Struttura Complessa Oncologia Medica Azienda Ospedaliero-Universitaria di Parma (Site 607) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Korea, Republic of

Goyang-si : National Cancer Center (Site 916) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : The Catholic University of Korea Seoul St. Mary's Hospital (Site 938) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : Severance Hospital, Yonsei University Health System (Site 913) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : Seoul National University Hospital (Site 915) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : Asan Medical Center (Site 917) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Lithuania

Vilnius : Institute of Oncology, Vilnius University

A clinical trial to evaluate treatments using Amphinex induced PCI of bleomycin for patients with Recurrent Cancer

Netherlands

Amsterdam : The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital

A clinical trial to evaluate treatments using Amphinex induced PCI of bleomycin for patients with Recurrent Cancer

Groningen : University Medical Center Groningen (Site 581) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Masstricht : Maastricht UMC+ (Site 580) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Singapore

Singapore : National Cancer Centre Singapore, Depart of Medical Oncology (Site 989) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Singapore : OncoCare Cancer Centre (Site 988) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Spain

A Coruna : Hospital Teresa Herrera (Site 554) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Barcelona : Hospital Universitario Quiron Dexeus, Servicio de Oncologia Medica (Site 590) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Barcelona : Hospital Universitari de la Vall d'Hebron Servicio de Oncologia Medica (Site 503) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Madrid : Hospital Universitario La Paz (Site 582) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

United Kingdom

London : University College London Hospital

A clinical trial to evaluate treatments using Amphinex induced PCI of bleomycin for patients with Recurrent Cancer

Stay Informed
Sign up for e-newsletters, major
events and research alerts!

3520 Lake Ave., Ste 202, Wilmette, IL 60091 | Office: 847.424.0600 | Fax: 847.424.0606 | Contact Us